Published in Int J Hyg Environ Health on September 21, 2007
Shiga toxin: expression, distribution, and its role in the environment. Toxins (Basel) (2011) 1.12
Impact of Some Ecological Factors on Fecal Contamination of Drinking Water by Diarrheagenic Antibiotic-Resistant Escherichia coli in Zagazig City, Egypt. Int J Microbiol (2016) 0.75
Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J Am Soc Nephrol (2005) 3.57
New approaches to the treatment of dense deposit disease. J Am Soc Nephrol (2007) 3.02
Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J Infect Dis (2002) 2.89
Livestock-associated methicillin-resistant Staphylococcus aureus in humans, Europe. Emerg Infect Dis (2011) 2.35
An outbreak of Norovirus infection affecting an Austrian nursing home and a hospital. Wien Klin Wochenschr (2005) 2.18
Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol (2005) 1.87
Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome. N Engl J Med (2010) 1.80
Complement in human diseases: Lessons from complement deficiencies. Mol Immunol (2009) 1.73
Complement resistance mechanisms of streptococci. Mol Immunol (2003) 1.56
Classifying spa types in complexes improves interpretation of typing results for methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2006) 1.50
Complement evasion of pathogens: common strategies are shared by diverse organisms. Mol Immunol (2007) 1.49
[Food borne infectious outbreaks, Austria 2005]. Wien Klin Wochenschr (2007) 1.48
The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome. Diagn Microbiol Infect Dis (2007) 1.48
Complement escape of human pathogenic bacteria by acquisition of complement regulators. Mol Immunol (2006) 1.46
Influenza-related excess mortality, Austria 2001 till 2009. Wien Klin Wochenschr (2011) 1.44
Co-infection with two Chlamydophila species in a case of fulminant myocarditis. Crit Care Med (2007) 1.43
Epidemiology of enterovirus types causing neurological disease in Austria 1999-2007: detection of clusters of echovirus 30 and enterovirus 71 and analysis of prevalent genotypes. J Med Virol (2009) 1.43
Infection of red deer, cattle, and humans with Mycobacterium bovis subsp. caprae in western Austria. J Clin Microbiol (2002) 1.37
Rapid identification of multidrug-resistant Mycobacterium tuberculosis isolates by rpoB gene scanning using high-resolution melting curve PCR analysis. J Antimicrob Chemother (2009) 1.30
Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome. J Immunol (2009) 1.29
Circulating cytotoxic CD8(+) CD28(-) T cells in ankylosing spondylitis. Arthritis Res (2001) 1.26
Listeria rocourtiae sp. nov. Int J Syst Evol Microbiol (2009) 1.21
Antimicrobial susceptibilities of Austrian Francisella tularensis holarctica biovar II strains. Int J Antimicrob Agents (2005) 1.20
Variability in tellurite resistance and the ter gene cluster among Shiga toxin-producing Escherichia coli isolated from humans, animals and food. Res Microbiol (2006) 1.19
Complement-HIV interactions during all steps of viral pathogenesis. Vaccine (2007) 1.19
Healthy aging and latent infection with CMV lead to distinct changes in CD8+ and CD4+ T-cell subsets in the elderly. Hum Immunol (2006) 1.17
CD25-expressing CD8+ T cells are potent memory cells in old age. J Immunol (2005) 1.16
Recombinant HIV-1 Pr55gag virus-like particles: potent stimulators of innate and acquired immune responses. Mol Immunol (2005) 1.15
Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol (2012) 1.14
Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae. Clin Infect Dis (2012) 1.13
Potential basis for amphotericin B resistance in Aspergillus terreus. Antimicrob Agents Chemother (2008) 1.11
Prevalence, clinical relevance and characterization of circulating cytotoxic CD4+CD28- T cells in ankylosing spondylitis. Arthritis Res Ther (2003) 1.11
Phagocytosis and killing of bacteria by professional phagocytes and dendritic cells. Clin Diagn Lab Immunol (2002) 1.10
Cutting edge: productive HIV-1 infection of dendritic cells via complement receptor type 3 (CR3, CD11b/CD18). J Immunol (2004) 1.10
Complement-opsonized HIV: the free rider on its way to infection. Mol Immunol (2005) 1.09
Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples. J Clin Microbiol (2004) 1.08
A large family with a gain-of-function mutation of complement C3 predisposing to atypical hemolytic uremic syndrome, microhematuria, hypertension and chronic renal failure. Clin J Am Soc Nephrol (2009) 1.07
Thymectomy in early childhood: significant alterations of the CD4(+)CD45RA(+)CD62L(+) T cell compartment in later life. Clin Immunol (2008) 1.07
Hemolytic-uremic syndrome associated with enterohemorrhagic Escherichia coli O26:H infection and consumption of unpasteurized cow's milk. Int J Infect Dis (2003) 1.07
Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions. J Immunol (2013) 1.06
Role of complement in the control of HIV dynamics and pathogenesis. Vaccine (2003) 1.06
Multiple-locus variable-number tandem repeat analysis for subtyping of Salmonella enterica subsp. enterica serovar Enteritidis. Int J Med Microbiol (2008) 1.05
HIV-infection of the central nervous system: the tightrope walk of innate immunity. Mol Immunol (2005) 1.04
Identifying and subtyping species of dangerous pathogens by automated ribotyping. Diagn Microbiol Infect Dis (2003) 1.04
Epidemiology of listeriosis in Austria. Wien Klin Wochenschr (2009) 1.04
EspP, a serine protease of enterohemorrhagic Escherichia coli, impairs complement activation by cleaving complement factors C3/C3b and C5. Infect Immun (2010) 1.02
IgG opsonization of HIV impedes provirus formation in and infection of dendritic cells and subsequent long-term transfer to T cells. J Immunol (2007) 1.02
Factor I-mediated processing of complement fragments on HIV immune complexes targets HIV to CR2-expressing B cells and facilitates B cell-mediated transmission of opsonized HIV to T cells. J Immunol (2006) 1.01
Cross-linking of CD32 induces maturation of human monocyte-derived dendritic cells via NF-kappa B signaling pathway. J Immunol (2003) 1.00
The impact of Rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infections. BMC Infect Dis (2013) 1.00
Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. J Virol (2002) 1.00
Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers. Vaccine (2006) 0.99
Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro. Antimicrob Agents Chemother (2008) 0.98
Impact of N-chlorotaurine on viability and production of secreted aspartyl proteinases of Candida spp. Antimicrob Agents Chemother (2002) 0.97
Susceptibility testing of anidulafungin and voriconazole alone and in combination against conidia and hyphae of Aspergillus spp. under hypoxic conditions. Antimicrob Agents Chemother (2008) 0.97
Lessons learned from a Salmonella enteritidis phage type 4 outbreak in Austria, 2005. J Food Prot (2007) 0.97
Autochthonous Dirofilaria repens in Austria. Parasit Vectors (2014) 0.97
Molecular typing of Aspergillus terreus isolates collected in Houston, Texas, and Innsbruck, Austria: evidence of great genetic diversity. J Clin Microbiol (2007) 0.96
Occurrence of Vibrio cholerae serogroups other than O1 and O139 in Austria. Wien Klin Wochenschr (2007) 0.96
Human platelets attenuate Aspergillus species via granule-dependent mechanisms. J Infect Dis (2008) 0.96
An unusual cause of sepsis during pregnancy: recognizing infection with chlamydophila abortus. Obstet Gynecol (2005) 0.95
Terminal complement complex (C5b-9) in children with recurrent hemolytic uremic syndrome. Semin Thromb Hemost (2006) 0.95
HIV-1 induces complement factor C3 synthesis in astrocytes and neurons by modulation of promoter activity. Mol Immunol (2004) 0.95
Mechanisms behind variation in the Clostridium difficile 16S-23S rRNA intergenic spacer region. J Med Microbiol (2010) 0.94
One-step triplex high-resolution melting analysis for rapid identification and simultaneous subtyping of frequently isolated Salmonella serovars. Appl Environ Microbiol (2012) 0.94
Gene Scanning of an Internalin B Gene Fragment Using High-Resolution Melting Curve Analysis as a Tool for Rapid Typing of Listeria monocytogenes. J Mol Diagn (2010) 0.94
HIV-1-induced migration of monocyte-derived dendritic cells is associated with differential activation of MAPK pathways. J Immunol (2004) 0.93
Outbreak of leptospirosis among triathlon participants in Langau, Austria, 2010. Wien Klin Wochenschr (2011) 0.93
An outbreak of norovirus gastroenteritis in an Austrian hospital, winter 2006-2007. Wien Klin Wochenschr (2009) 0.92
Posaconazole enhances the activity of amphotericin B against Aspergillus hyphae in vitro. Antimicrob Agents Chemother (2006) 0.92
C-type lectin-independent interaction of complement opsonized HIV with monocyte-derived dendritic cells. Eur J Immunol (2005) 0.92
A single vaccination with attenuated SIVmac 239 via the tonsillar route confers partial protection against challenge with SIVmac 251 at a distant mucosal site, the rectum. Front Biosci (2007) 0.92
Complement dependent trapping of infectious HIV in human lymphoid tissues. AIDS (2005) 0.92
Prevention and treatment of enterohemorrhagic Escherichia coli infections in humans. Expert Rev Anti Infect Ther (2008) 0.91
C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function. Blood (2009) 0.91
Diagnosis of bacteria in vitro by mass spectrometric fingerprinting:a pilot study. Curr Microbiol (2005) 0.91
An outbreak of febrile gastroenteritis associated with jellied pork contaminated with Listeria monocytogenes. Wien Klin Wochenschr (2009) 0.91
Antibody-dependent killing of meningococci by human neutrophils in serum of late complement component-deficient patients. Int Arch Allergy Immunol (2003) 0.90
Detection of virulence-associated and regulatory protein genes in association with phage typing of human Vibrio cholerae from several geographical regions of the world. J Med Microbiol (2009) 0.90
A foodborne outbreak of Salmonella Enteritidis phage type 6 in Austria, 2008. Wien Klin Wochenschr (2009) 0.90
The vesicle transport protein Vac1p is required for virulence of Candida albicans. Microbiology (2006) 0.90
Evidence for complement activation in ruptured coronary plaques in acute myocardial infarction. Am J Cardiol (2002) 0.89
Clostridium difficile: a new zoonotic agent? Wien Klin Wochenschr (2009) 0.89